Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Contemporary Clinical Trials
|
September 25, 2012
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes
Scott D Ramsey, William E Barlow, Ana M Gonzalez-Angulo, et al.
Plos One
|
February 14, 2018
Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries
Katherine Davis, Sarah L Gorst, Nicola Harman, et al.
Annals of Internal Medicine
|
August 17, 2005
Promoting informed choice: transforming health care to dispense knowledge for decision making
Steven H Woolf, Evelyn C Y Chan, Russell Harris, et al.
BMJ Open Diabetes Research & Care
|
January 8, 2020
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
Nicola L Harman, John P H Wilding, Dave Curry, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
January 25, 2013
Building a strategic framework for comparative effectiveness research in complementary and integrative medicine
Claudia M Witt, Margaret Chesney, Richard Gliklich, et al.
Clinical Trials (London, England)
|
February 16, 2012
Panel discussion 1
Sandy Schwartz, Michael Lauer, Barbara McNeil, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 19, 2023
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal
Mondher Toumi, Omar Dabbous, Samuel Aballéa, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 18, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Kevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Journal of Clinical Epidemiology
|
April 8, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Kevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Health Policy (Amsterdam, Netherlands)
|
November 12, 2021
Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe
Sean Tunis, Eve Hanna, Peter J Neumann, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Contemporary Clinical Trials
|
September 25, 2012
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes
Scott D Ramsey, William E Barlow, Ana M Gonzalez-Angulo, et al.
Plos One
|
February 14, 2018
Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries
Katherine Davis, Sarah L Gorst, Nicola Harman, et al.
Annals of Internal Medicine
|
August 17, 2005
Promoting informed choice: transforming health care to dispense knowledge for decision making
Steven H Woolf, Evelyn C Y Chan, Russell Harris, et al.
BMJ Open Diabetes Research & Care
|
January 8, 2020
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
Nicola L Harman, John P H Wilding, Dave Curry, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
January 25, 2013
Building a strategic framework for comparative effectiveness research in complementary and integrative medicine
Claudia M Witt, Margaret Chesney, Richard Gliklich, et al.
Clinical Trials (London, England)
|
February 16, 2012
Panel discussion 1
Sandy Schwartz, Michael Lauer, Barbara McNeil, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 19, 2023
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal
Mondher Toumi, Omar Dabbous, Samuel Aballéa, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 18, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Kevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Journal of Clinical Epidemiology
|
April 8, 2009
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Kevin E Thorpe, Merrick Zwarenstein, Andrew D Oxman, et al.
Health Policy (Amsterdam, Netherlands)
|
November 12, 2021
Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe
Sean Tunis, Eve Hanna, Peter J Neumann, et al.
Page
of 7